Therapeutic Glaucoma

Controlling glaucoma uncertainty as COVID-19 limitations continue

Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.

Combination drops may help patients challenged by multiple glaucoma meds

Drops can simplify dosing, improving adherence and ocular surface health

MIGS, other options offer hope for angle-closure patients

Intraocular drainage surgery may have a future for treating issues.

Glaukos COO shares product updates, 2021 pipeline

January 31, 2021

Glaukos Corporation's COO Chris Calcaterra gives an update on the company's latest 24-month phase 2b data for its iDose TR sustained-release travoprost implant, next steps for securing FDA approval, and his outlook for 2021.